MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Research

remyelination research

Remyelination in Multiple Sclerosis: New Insights

MStranslate
January 16, 2023
Dr Travis Stiles, ECTRIMS, Remyelination, Research
1 Comment
Late in 2022, we published two new videos that provided insights on the topic of remyelination research in multiple sclerosis (MS). The first...
multiple sclerosis nurses

The Value of Specialist Multiple Sclerosis Nurses

MStranslate
November 29, 2022
ECTRIMS, Research, Videos
At the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, Belinda Bardsley (Austin Health, Australia)...
ECTRIMS 2022

ECTRIMS 2022: Daily Podcasts & Summary Videos

MStranslate
November 21, 2022
Conferences, ECTRIMS, Research
The 38th meeting of the European Congress for the Treatment and Research Into Multiple Sclerosis (ECTRIMS) took place in Amsterdam, The Netherlands,...
Facebook Live

Facebook Live: Special Guest Announcement

MStranslate
September 28, 2022
Dr Travis Stiles, Q&A, Research, Videos
On September 25, 2022, our co-founder and chief science communicator, Brett Drummond, took to Facebook Live with a very special guest, Dr Travis...
Digoxin

Heart Medication Shows Potential to Repair Myelin

MStranslate
August 16, 2022
Remyelination, Research, Treatments
Research Summary: Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models...
epstein-barr virus

How Could Epstein-Barr Virus Trigger MS?

MStranslate
July 21, 2022
Epstein-Barr virus, Research
1 Comment
In this third instalment of our video series on Epstein-Barr virus (EBV) and its potential role in multiple sclerosis (MS), our co-founder and chief...
epstein-barr virus

EBV T-Cell Treatment for MS: Trial Update

MStranslate
July 13, 2022
Epstein-Barr virus, Progressive MS, Research, Treatments
Research Update: ATA188 Phase 2 EMBOLD Study Today, Atara Biotherapeutics provided an update on their Phase 2 randomised clinical trial, called the...
Epstein-Barr virus

Study Shows How EBV May Help Trigger MS

MStranslate
June 29, 2022
Epstein-Barr virus, Research
Research Summary: Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM New studies linking Epstein-Barr virus (EBV) to...
Dr Barry Singer

ACTRIMS Forum 2022 Insights – Dr Barry Singer

MStranslate
April 4, 2022
ACTRIMS, Conferences, Research
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) held its annual meeting between February 24 and 26 in West Palm...
milk multiple sclerosis

Does Drinking Cow’s Milk Worsen MS Symptoms?

MStranslate
March 10, 2022
Diet, Research, Symptoms
A new study from the University of Bonn has investigated whether a protein found in cow's milk can lead to damage of the central nervous system....
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.